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Abstract Aspergilli have a long history in biotech-
nology as expression platforms for the production of
food ingredients, pharmaceuticals and enzymes. The
achievements made during the last years, however,
have the potential to revolutionize Aspergillus
biotechnology and to assure Aspergillus a dominant
place among microbial cell factories. This mini-
review will highlight most recent breakthroughs in
fundamental and applied Aspergillus research with a
focus on new molecular tools, techniques and prod-
ucts. New trends and concepts related to Aspergillus
genomics and systems biology will be discussed as
well as the challenges that have to be met to integrate
omics data with metabolic engineering attempts.
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Introduction
There are about 250 named species in the genus
Aspergillus (Geiser et al. 2007), including important
industrially exploited species (A. niger, A. oryzae,
A. awamori, A. sojae, A. terreus) and harmful species
being pathogenic to animals and/or plants (e.g.
A. fumigatus, A. parasiticus, A. ﬂavus). Due to their
extraordinary metabolic versatility, aspergilli are
used in biotechnology for the production of a variety
of products such as organic acids, pharmaceuticals,
proteins and enzymes (for reviews see (Meyer 2008;
Lubertozzi and Keasling 2009)). Aspergillus stands
out from other microbial cell factories of bacterial or
yeast origin due to its ability to tolerate extreme
cultivation conditions (Raper and Fennel 1965;
Kis-Papo et al. 2003; Machida and Gomi 2010). For
example, Aspergillus can be cultivated over a wide
range of temperatures (10–50C), pH (2–11), salinity
(0–34%), water activity (0.6–1) and under oligo-
trophic or nutrient-rich conditions. Hence, Aspergillus
can be used for solid-state or submerged fermenta-
tions and respective fermentation protocols have
been established for large-scale industrial processes.
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diverse biopolymers such as starch, (hemi-)cellulose,
pectin, xylan and proteins, allowing it to be cultivated
on renewable resources such as plant biomass.
As of 2010, ten genome sequences of the most
important industrial and medical Aspergilli are pub-
lically accessible, making this genus one of the best to
be studied by comparative genome analysis. This
resource has spurred multiple research activities,
including functional genomics and systems biology
attempts aiming at the identiﬁcation of new leads for
strain development and at the understanding of the
onset and progression of Aspergillus diseases. The
aim of this mini-review is to highlight recent break-
throughs in fundamental and applied Aspergillus
research, focusing on new tools, techniques and
products and to discuss new trends, concepts and
challenges important for future strain development
programs in the post-genomic era.
Genetic tools
Although Aspergillus shares with bacterial and yeast
cell factories much of their ease of cultivation, the
knowledge on how to genetically dissect and engineer
industrial Aspergillus strains lagged behind for a long
time.However,thepastdecadeofAspergillusresearch
has been a fascinating period of new discoveries and
breakthroughs, which resulted in many new genetic
tools and techniques. These include the establishment
of (i) efﬁcient genetic transformation systems, (ii)
high-throughput gene targeting tools, (iii) expression
systems for high level and controlled protein produc-
tionand(iv)live-imagingtechniquesforcellbiological
studies. In the following, some of these development
will be touched, however, for more in-depth informa-
tion, the reader is directed to the following reviews
(Meyer 2008; Hickey and Read 2009; Lubertozzi and
Keasling 2009; Fleissner and Dersch 2010;K u ¨ck and
Hoff 2010; Meyer et al. 2010a).
Genetic manipulation
For a long time, genetic manipulation of industrially
used Aspergillus strains was hampered due to the lack
of efﬁcient genetic transformation systems, limited
availability of selection markers and low gene
targeting efﬁciencies (usually around 1–5%). All
three problems have been solved during the last
decade. Protoplast-mediated transformation became
the method of choice to efﬁciently transform A. niger,
A. oryzae, A. sojae and A. terreus, whereas Agrobac-
terium-mediated transformation is most efﬁcient for
A. awamori (reviewed by (Michielse et al. 2005;
Meyer 2008)). In addition, versatile selection systems
including antibiotic resistance markers (hph, ble,
oliC3), auxotrophic markers (pyrG, pyrE, argB,
adeA, adeB, niaD, trpC, sC) and nutritional markers
(amdS, ptrA) in combination with integrative and
autonomously replicating vectors have been devel-
oped, offering nowadays highest ﬂexibility for
genetic manipulation of industrial Aspergillus strains
(Jin et al. 2004; Carvalho et al. 2010a; Fleissner and
Dersch 2010; Meyer et al. 2010a). In this context, it is
worth emphasizing that the usage of the counter-
selectable markers pyrE, pyrG and amdS does fulﬁll
the requirements of the European Union for self-
cloning approaches. An interesting alternative option
for efﬁcient marker recycling and removal of heter-
ologous DNA sequences makes use of the yeast
FLP/FRT recombination system. This system was
recently adapted for the penicillin producer Penicil-
lium chrysogenum (Kopke et al. 2010) and is likely to
be applicable to Aspergillus as well.
A quantum leap for molecular Aspergillus research
was based on a ﬁnding made in the fungal model
organism Neurospora crassa. Here it was observed
that homologous recombination frequencies can
increase up to 100%, when the recipient strain is
deﬁcient for the non-homologous end joining (NHEJ)
pathway (Ninomiya et al. 2004). This ﬁnding was
conﬁrmed in many aspergilli including A. oryzae,
A. sojae and A. niger (Takahashi et al. 2006; Meyer
etal.2007;Mizutanietal.2008;Carvalhoetal.2010a)
and many recipient strains are now available in which
the NHEJ pathway is permanently or transiently
inactivated (reviewed in (Meyer 2008;K u ¨ck and Hoff
2010)). This discovery made genome-wide deletion
projects feasible, the ﬁrst of which was launched in
2007 for N. crassa (www.dartmouth.edu/*neuro
sporagenome/) followed by the A. nidulans project in
2010 (www.fgsc.net/Aspergillus/KO_Cassettes.htm).
Expression systems
A comprehensive review on different expression
system for recombinant protein production in
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123Aspergillus was most recently given (Fleissner and
Dersch2010).Abouttwodozen Aspergilluspromoters
are available for high-yield production of homologous
and heterologous proteins. The promoters used are
either constitutively active (e.g. the glyceraldehyde-3-
phosphate dehydrogenase promoter PgpdA) or are
inducible based on the carbon source present in the
fermentationmedium(e.g.theglucoamylasepromoter
PglaA,thealcoholdehydrogenasepromoterPalcA,the
a-amylase promoter PamyA). However, none of the
available promoters allows tight, tunable and carbon
source-independent expression control, posing limita-
tions in their use. To overcome this problem, an
artiﬁcial gene expression system based on the Esch-
erichia coli tetracycline-resistance operon (Tet-On/
Tet-Off system) was adopted for use in A. fumigatus
(Vogt et al. 2005). The Tet-On system was further
reﬁnedforuseinA.nigerandsystematicallyevaluated
(Meyer et al. 2010b). The data obtained showed that
the Tet-On system is tight under non-induced condi-
tions, is able to respond within minutes after inducer
addition and allows tunable gene control in a gene
dosage and/or inducer concentration dependent man-
ner. Most importantly, the strength of the A. niger Tet-
On system can compete with the gpdA promoter,
making it as a very promising tool for future protein
overproductions in Aspergillus.
Omics tools
The sequencing of fungal genomes led Aspergillus
research into a new era referred to as systems
biology. Instead of studying one gene or protein at
a time, the complete set of genes, proteins and/or
metabolites are studied simultaneously, aiming at a
comprehensive understanding of the robustness, via-
bility and productivity of industrial Aspergillus
strains and at the identiﬁcation of factors important
for pathogenicity of medical Aspergilli. For each of
the omics subdisciplines (transcriptomics, proteo-
mics, metabolomics) a dedicated set of equipment,
techniques and software tools has to be developed, a
process which is still on-going for many Aspergillus
species. For the whole genus, only about 30 omics
studies appear yearly in Pubmed (Fig. 1), illustrating
that Aspergillus systems biology is still in its infancy.
Among these, the following publications on industri-
ally used Aspergilli are worth highlighting: (i) a
metabolic network was established for A. niger and
A. oryzae based on genomic databases and extensive
literature surveys (Andersen et al. 2008; Vongsang-
nak et al. 2008). (Note that a web-based pathway
viewer has recently been launched for A. fumigatus
(Tuckwell et al. 2010.) (ii) The starch-, pectin- and
inulin-degrading enzyme network of A. niger was
identiﬁed using a combined database mining and
transcriptomic approach (Martens-Uzunova et al.
2006; Yuan et al. 2006, 2008; Martens-Uzunova
and Schaap 2009). (iii) An integrated transcriptomics
and proteomics approach identiﬁed new leads for
improved protein secretion of A. niger (Guillemette
et al. 2007; Levin et al. 2007; Jacobs et al. 2009). (iv)
A transcriptomics and genetic study predicted regu-
latory networks important for the morphological
control of A. niger growth (Meyer et al. 2009).
(v) A transcriptomics and metabolomics study dis-
closed regulatory genes involved in lovastatin bio-
synthesis in A. terreus (Askenazi et al. 2003). (vi) A
transcriptome analysis identiﬁed genes important for
high-yield solid-phase fermentations in A. oryzae
(Tamano et al. 2008).
Key for systems biology attempts is the availability
of well-annotated genome sequences, standardized
analysis tools (e.g. microarray platforms, RNA
sequencing technologies, high-throughput chromato-
graphic separations and mass spectrometry tools) and
suitably conﬁgured databases for data storage and
networkreconstruction.Mostrecently,theopenaccess
online tool ‘BioMet toolbox’ has been launched
(www.sysbio.se/BioMet/) which allows integration
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Fig. 1 Number of Aspergillus omics articles published over
the last years in Pubmed (by October 2010)
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123and systematic analysis of omics data from A. niger
andA.oryzae(Cvijovicetal.2010).Amajorchallenge
in systems biology approaches is the fact that the data
gained has varying levels of reliability. Data-sets can
be error prone due to technical irreproducibility, e.g.
cultivations of Aspergillus performed in shake ﬂasks
are not reproducible due to continuous changes in pH,
temperature, oxygen availability and eventually in
morphology. In contrast, cultivations in lab-scale
bioreactors allow on-line control on these parameters
and thus ensure highest reproducibility (Jorgensen
et al. 2010; Meyer et al. 2010a). Besides technical
problems, biological variations caused by heteroge-
neous gene expression in Aspergillus populations
(Vinck et al. 2005; Levin et al. 2007) will introduce
errors as well. Hence, the application of statistical
procedures and bioinformatics pipelines for handling
and modeling errors as well as internal controls are
crucial to gain legitimate interpretations out from
high-throughput omics data.
Strain developments
A. niger, A. oryzae and A. awamori are well-
established expression platforms for the production
of secreted proteins and enzymes (Punt et al. 2002).
However, their productivities are limited due to
several reasons. First, the protein of interest can
become degraded by secreted host proteases, the
number of which was estimated to be 200 in A. niger
(Pel et al. 2007). To tailor the host protease proﬁle,
several approaches have been followed, including
deletion or silencing of selected protease genes in
A. oryzae or A. awamori (Moralejo et al. 2002; Yoon
et al. 2009) and deletion of the protease-speciﬁc
transcription factor PrtT in A. niger and A. oryzae
(Punt et al. 2008). Second, low yields are often
observed when proteins of non-fungal origin have to
be expressed. It is thought that this results from
intracellular misfolding of the target proteins, an
event, which initiates compensatory responses in
Aspergillus such as ERAD (ER-associated degrada-
tion; sensing and removal of misfolded proteins via
the proteasome) and UPR (unfolded protein response;
degradation or refolding of unfolded proteins). To get
insights into the genetic repertoire securing protein
secretion, ERAD and UPR, transcriptomics and
functional genomics approaches have recently been
undertaken in A. niger (Guillemette et al. 2007;
Jorgensen et al. 2009; Carvalho et al. 2010b) and
A. oryzae (Wang et al. 2010), to name but a few. In
order to tackle intracellular degradation of the target
protein, the ‘carrier approach’ is one option, where
the protein of interest is genetically fused to an
abundantly secreted host protein (Punt et al. 2002).
An additional promising approach is the optimisation
of the codon usage of the gene of interest according
to the preferred codon-usage of the expression host
(Roubos and van Peij 2008). Finally, protein engi-
neering approaches aiming at increased protein
stabilities hold promise as well (Kumita et al. 2006).
A third, long-lasting and still unsolved problem is
related to the morphology of Aspergillus. As with all
ﬁlamentous fungi, either freely dispersed ﬁlaments or
highly compact pellets can be formed during
submerged fermentations, both of which do limit
process productivity (Papagianni 2004; Grimm et al.
2005). So far, the formation of these macroscopic
morphologies can only descriptively be monitored
but not controlled. To overcome this constraint and to
optimize the morphology by rational genetic engi-
neering, transcriptomics and functional genomics
studies have recently been initiated aiming at the
reconstruction of the morphogenetic machinery of
A. niger (Meyer et al. 2008, 2009).
New products in the post-genomic era
The availability of Aspergillus genome sequences has
triggered an area of research called ‘genome mining’
which assumes that Aspergillus can be a source of
new products such as therapeutics or drugs. Indeed,
genome analyses disclosed more genes involved in
secondary metabolite (SM) synthesis than antici-
pated. The respective pathway genes are conveniently
arranged in gene clusters (30–40 clusters are typically
found in Aspergilli), and have been predicted to be
involved in the synthesis of various polyketides or
non-ribosomal peptides (Brakhage and Schroeckh
2010). To facilitate the systematic mining and
mapping of these clusters, the web-based tool
SMURF (Secondary Metabolite Unknown Regions
Finder; www.jcvi.org/smurf/) has recently been
launched as open access bioinformatics tool (Khaldi
et al. 2010). However, most SM clusters are silent
or cryptic, i.e. are not expressed under laboratory or
472 Biotechnol Lett (2011) 33:469–476
123industrial conditions (Pel et al. 2007). To activate
expression of silent clusters and to identify the
metabolite(s) produced, different strategies based on
molecular, epigenetics and cultivation methods have
been undertaken in Aspergillus and recently reviewed
(Chiang et al. 2009; Brakhage and Schroeckh 2010).
Among these, four approaches stand out. First, it was
reported that controlled activation of a pathway-spe-
ciﬁc transcription factor in the model A. nidulans
activated a silent metabolic pathway, as a result of
which two novel SM were identiﬁed (Bergmann et al.
2007). Second, targeted manipulation of the chro-
matin state, i.e. removal of a chromatin silencing
gene, activated expression of at least two other gene
clusters (Bok et al. 2009). Thirdly, it was shown that
an intimate physical interaction during fungal-bacte-
rial co-cultivations is the prerequisite for selective
activation of another SM cluster (Schroeckh et al.
2009). And ﬁnally, cultivation at very low speciﬁc
growth rates, which almost reached zero-growth
conditions, induced expression of SM clusters in
A. niger (Jorgensen et al. 2010). Hence, multiple
approaches can be followed or combined to fully
harness the SM potential of Aspergilli.
Lubertozzi and Keasling (2009) list in their
comprehensive review many more potential natural
Aspergillus products with commercial relevance, an
impressive list that emphasises the great potential of
Aspergillus to become a multi-purpose expression
platform. Besides polyketides and non-ribosomal
peptides as potential therapeutic agents, isoprenoids
are interesting as new neutraceuticals or aroma
compounds, lipopeptides and AFP-derived proteins
as new antifungals and poly-unsaturated fatty acids or
lipids as food additives or fuel feedstocks. Moreover,
the future product spectrum of industrial Aspergillus
strains is not restricted to its natural genetic reper-
toire. The new genetic engineering toolkit for Asper-
gillus and the advent of synthetic biology open new
avenues to many more compounds of (non)fungal
origin to be expressed and produced in Aspergillus.
New concepts and perspectives
To fully explore and exploit Aspergillus as a multi-
purpose expression platform, conceptually new
approaches will be followed, some of which have the
potential to revolutionize Aspergillus biotechnology.
It is likely that newly engineered production strains
will be completely devoid of unwanted SM gene
clusters and used as chassis for the production of food
and feed ingredients, enzymes, pharmaceuticals or
even fuel feedstocks. The gene(s) or gene cluster(s) of
interest will be of Aspergillus or (non)fungal origin
and polished according to the Aspergillus codon-bias.
Expression constructs will be plugged into selected
genomic loci allowing highest control over gene
expression. The gene(s) of interest will be expressed
under the control of constitutive or inducible promot-
ers, depending on the toxicity of the ﬁnal product. The
productrepertoire,thetimingofproductformationand
productivity will be optimised using different cultiva-
tionstrategies.Forexample,fermentationsunderzero-
growth conditions can uncouple growth from product
formation and have the potential to improve SM
production (Jorgensen et al. 2010).
In addition, vesicle and organelle engineering
approaches offer exciting opportunities. For example,
intracellular proteins can become secreted via ‘per-
oxicretion’, an artiﬁcial route where proteins become
targeted to peroxisomes which themselves have
genetically been decorated with v-SNARES. They
ensure transport of the peroxisomes to the plasma
membrane, where the protein cargo becomes released
into the medium (Sagt et al. 2009). Moreover, SM
production can be improved by optimizing the
volume fraction of organelles in which (part of) SM
biosynthesis takes place. A proof-of-concept was
recently shown for penicillin synthesis in Penicillium
chrysogenum, where artiﬁcially induced proliferation
of peroxisomes resulted in increased penicillin titres
(Kiel et al. 2005; Meijer et al. 2010). Most interest-
ingly, natural product formation in Aspergillus can
also be dependent on the circadian rhythm—not only
in the case for SM as known for a long time
(Brakhage and Schroeckh 2010), but likely also in the
case of secreted enzymes as shown for cellulase
production in the industrial fungus Trichoderma
reesei (Castellanos et al. 2010). Hence, understanding
circadian regulatory mechanisms might also give new
leads for genetic engineering strategies.
What is pivotal to successfully merge Aspergillus
biotechnology, systems biology tools and metabolic
engineering attempts? Controlled cultivation and
harvesting conditions for Aspergillus as well as
standardised methodological and bioinformatics
tools are crucial to deduce accurate and meaningful
Biotechnol Lett (2011) 33:469–476 473
123conclusions out from transcriptome, proteome and
metabolome data. Genome-wide metabolic models
and metabolic ﬂux analyses are key for the identiﬁ-
cation of pathway limitations and predicting beneﬁ-
cial metabolic engineering strategies. However, to
fully describe and engineer cellular phenomena in
Aspergillus, the implementation of cell biological
studies such as in vivo live imaging are required.
Only the understanding of compartmentalized prod-
uct biosynthesis as well as transport and trafﬁc
phenomena will uncover the link between morphol-
ogy, secretion and product formation in Aspergillus
and will eventually give signiﬁcant leads for rede-
signing this versatile expression host.
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